WhiteNJ. Antimalarial drug resistance: the pace quickens. J Antimcrob Chemother1992; 30: 571–85
2.
NevillCGVerhoeffFHMunafuCGten HoveWRvan der KaayHJWereJB. A comparison of amodiaquine and chloroquine in the treatment therapy of falciparum malaria in Kenya. E Afr Med J1994; 71: 167–70
3.
OlliaroPNevillCLebrasJ, Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet1996; 348: 1196–201
4.
MullerOvan HensbroekMBJaffarS, A randomized trial of chloroquine, amodiaquine and pyrimethamine—sulphadoxine in Gambian children with uncomplicated malaria. Trop Med Int Health1996; 1: 124–32
5.
SmithuisFMMontiFGrundiMOoA ZawKyawTTPheOWhiteNJ. In vivo sensitivity of Plasmodium falciparum to chloroquine, sulphadoxine—pyrimethamine, and mefloquine in Rakhine Staet, Western Myanmar. Trans R Soc Trop Med Hyg1997; 91: 468–72
6.
WatkinsWMMosoboM. Treatment of Plasmodium falciparum malaria with pyrimethamine—sulfadoxine: selective pressure for resistance is a function of long elimination half-life. Trans R Soc Trop Med Hyg1993; 87: 75–8
7.
WatkinsWMBrandling-BennettADNevillCG, Chlorproguanil/dapsone for the treatment of non-severe Plasmodium falciparum infection in Kenya. Trans R Soc Trop Med Hyg1988; 82: 398–403
8.
EdsteinMDShanksGDIsavadharmP TejaRieckmannKHWebsterHK. Oxidative activation of proguanil and dapsone acetylation in Thai soldiers. Br J Clin Pharmacol1994; 37: 67–70
9.
LuxemburgerCPriceRNNostenFter KuileFChongsuphajaisiddhiTWhiteNJ. Mefloquine in infants and young children. Ann Trop Paediatr1996; 16: 281–6
10.
ter KuileFONostenFLuxemburgerC, Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious effects in 3673 patients. Bull WHO1995; 73: 631–42
11.
NostenFLuxemburgerCter KuileFO, Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate—mefloquine combination. J Infect Dis1994; 170: 971–7
12.
KremsnerPGWinklerSBrandtsCNeiferSBienzleUGraningerW. Clindamycin in combination with chloroquine or quinine is an effective therapy for uncomplicated Plasmodium falciparum malaria in children from Gabon. J Infect Dis1994; 169: 467–70
13.
LooareesuwanSWilairatanaPVanijanontaSKyleDWebsterK. Efficacy of quinine—tetracycline for acute uncomplicated falciparum malaria in Thailand. [Letter]. Lancet1992; 339: 369
14.
ter KuileFODolanGNostenF, Halofantrine versus mefloquine in the treatment of multi-drug resistant falciparum malaria. Lancet1993; 341: 1044–9
15.
NostenFter KuileFOLuxemburgerC, Cardiac effects of antimalarial treatment with halofantrine. Lancet1993; 341: 1054–6
16.
HienTTWhiteNJ. Qinghaosu. Lancet1993; 341: 603–8
17.
WhiteNJ. Preventing antimalarial drug resistance through combinations. Drug Resistance Updates1998; 1: 3–9
18.
van HensbroekMBOnyiorahEJaffarS, A controlled trial of artemether or quinine in children with cerebral malaria. N Engl J Med1996; 335: 69–75
19.
HienTTDayNPJPhuNH, A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med1996; 335: 76–83
20.
HienTTArnoldKVinhH, Comparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria. Trans R Soc Trop Med Hyg1992; 86: 582–3
21.
van VugtMBrockmanAGemperliB, A randomised comparison of artemether—benflumetol and artesunate—mefloquine in the treatment of multi-drug resistant falciparum malaria. Antimicrobial Agents Chemother1998; 42: 135–9
22.
LooareesuwanSKyleDEViravanCVanijanontaSWilairatanaPWernsdorferWH. Clinical study of pyronaridine for the treatment of acute uncomplicated flaciparum malaria in Thailand. Am J Trop Med Hyg1996; 54: 205–9
23.
LooareesuwanSViravanCWebsterHKKyleDEHutchinsonDBCanfieldCJ. Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg1996; 54: 62–6
